Related Experiment Video
Updated: Sep 20, 2025

13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
12.6K
Human Papillomavirus Vaccine Hesitancy and Barriers in Achieving 100% Vaccine Coverage: A Web-based Cross-sectional
Asmita Kaundal1, Prachi Renjhen2, Shikha Sharma3
1Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, Bilaspur, Himachal Pradesh, India.
Annals of African Medicine
|May 30, 2025
Summary
Vaccine hesitancy is a major barrier to HPV vaccine use in India. Unawareness about the human papillomavirus (HPV) vaccine
Area of Science:
- Oncology
- Vaccinology
- Public Health
Background:
- The human papillomavirus (HPV) vaccine is a critical tool for preventing HPV-related cancers and infections.
- Despite its availability for nearly two decades, HPV vaccination rates remain suboptimal globally and particularly in India.
- Understanding the drivers of vaccine hesitancy (VH) is crucial for improving HPV vaccine uptake.
Purpose of the Study:
- To investigate the primary reasons for vaccine hesitancy (VH) concerning the human papillomavirus (HPV) vaccine within the Indian population.
- To identify knowledge gaps and misconceptions surrounding HPV vaccination among Indian residents.
Main Methods:
- A web-based, cross-sectional study was conducted utilizing snowball sampling.
- A pre-validated 15-item questionnaire was distributed via social media platforms to assess causes of VH.
- Data from 1018 participants were analyzed.
Main Results:
- The majority of participants (64.1%) were aged 15-20 years; 60.5% were female.
- A significant proportion (80.9%) were unvaccinated, with unawareness cited as the main reason (38.2%).
- Limited awareness existed regarding the vaccine's target population (only 15.4% knew it was for both sexes) and its protective benefits against various cancers (15.9%).
Conclusions:
- Vaccine hesitancy, largely driven by a lack of awareness, significantly impedes HPV vaccine utilization in India.
- Targeted educational interventions are necessary to address knowledge deficits and promote HPV vaccination.
- Overcoming VH is essential for reducing the burden of HPV-related diseases nationwide.
Related Concept Videos
Vaccinations
45.4K
Overview
45.4K
Cancer Vaccines
522
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
522
Humoral Immune Responses
77.1K
Overview
77.1K
Bias in Epidemiological Studies
709
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
709

